ORION Corp. (KRX:271560)
South Korea · Delayed Price · Currency is KRW | Market Cap | 5.43T +24.5% |
| Revenue (ttm) | 3.46T +9.6% |
| Net Income | 402.86B -24.7% |
| EPS | 10,191.88 -24.7% |
| Shares Out | 39.53M |
| PE Ratio | 13.48 |
| Forward PE | 11.02 |
| Dividend | 2,500.00 (1.98%) |
| Ex-Dividend Date | Mar 30, 2026 |
| Volume | 122,719 |
| Open | 128,900 |
| Previous Close | 126,400 |
| Day's Range | 126,200 - 137,200 |
| 52-Week Range | 99,000 - 150,100 |
| Beta | 0.28 |
| Analysts | Buy |
| Price Target | 163,411.76 (+19.54%) |
| Earnings Date | Aug 14, 2026 |
About ORION
ORION Corp., together with its subsidiaries, engages in the manufacture and sale of various confectionery products in South Korea, China, and internationally. It offers pies, snacks, biscuits, candies, gums, and chocolates; protein drinks/powders and bars/balls bars; bar and oat products; and mineral water under the Dr.You, Market O, Market O Nature, and Jeju yongamsoo brands. The company also produces and distributes films; and provides in vitro diagnostics for early detection of cancer and vaccines for contagious diseases. In addition, it man... [Read more]
Financial Performance
In 2025, ORION's revenue was 3.33 trillion, an increase of 7.35% compared to the previous year's 3.10 trillion. Earnings were 382.71 billion, a decrease of -27.05%.
Financial StatementsAnalyst Summary
According to 17 analysts, the average rating for 271560 stock is "Buy." The 12-month stock price target is ₩163,412, which is an increase of 19.54% from the latest price.
News
Orion Corporation's financial reporting and Annual General Meeting in 2026
ORION CORPORATION STOCK EXCHANGE RELEASE – FINANCIAL CALENDAR 18 JULY 2025 at 9.30 EEST Orion Corporation's financial reporting and Annual General Meeting in 2026 Orion Corporation will publish its Fi...
Shilpa Medicare subsidiary partners with Orion Corporation to commercialize Recombinant Human Albumin in Europe
Shilpa Medicare Limited has announced that its wholly owned subsidiary, Shilpa Biocare Private Limited, has entered into a strategic agreement with Orion Corporation, a pharmaceutical company based in...